Stephen L. Silvestro
CIK: 0001773461
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OptimizeRx Corp
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 21, 2026OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.7K shares at avg. $7.71$13K - Aug 20, 2026OPRX
OptimizeRx Corp
Award(A)Direct79.2K shares- - May 15, 2026OPRX
OptimizeRx Corp
Tax Payment(F)Direct5.2K shares at avg. $5.21$27K - Dec 23, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct3.4K shares at avg. $12.74$43K - Dec 19, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.6K shares at avg. $13.51$22K - Dec 19, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct6.5K shares- - Oct 3, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct6.6K shares- - Oct 3, 2025OPRX
OptimizeRx Corp
Sale(S)Direct1.6K shares at avg. $18.75$30K - Aug 21, 2025OPRX
OptimizeRx Corp
Award(A)Direct15.6K shares- - May 15, 2025OPRX
OptimizeRx Corp
Award(A)Direct46.9K shares- - Mar 1, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct572 shares at avg. $5.18$3K - Mar 1, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct1.9K shares- - Feb 15, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct2.3K shares at avg. $6.64$15K - Dec 23, 2024OPRX
OptimizeRx Corp
Award(A)Direct41.4K shares- - Dec 19, 2024OPRX
OptimizeRx Corp
Exercise(M)Direct6.5K shares- - Dec 19, 2024OPRX
OptimizeRx Corp
Tax Payment(F)Direct2.6K shares at avg. $4.75$12K - Oct 3, 2024OPRX
OptimizeRx Corp
Tax Payment(F)Direct2.6K shares at avg. $7.83$20K - Oct 3, 2024OPRX
OptimizeRx Corp
Exercise(M)Direct6.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,737 | $7.71 | $13,392 | Direct |
| Aug 20, 2026 | OPRX OptimizeRx Corp | Award(A) | 79,200 | - | $0 | Direct |
| May 15, 2026 | OPRX OptimizeRx Corp | Tax Payment(F) | 5,219 | $5.21 | $27,191 | Direct |
| Dec 23, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 3,361 | $12.74 | $42,819 | Direct |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,594 | $13.51 | $21,535 | Direct |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 6,546 | - | - | Direct |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 6,649 | - | - | Direct |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Sale(S) | 1,620 | $18.75 | $30,375 | Direct |
| Aug 21, 2025 | OPRX OptimizeRx Corp | Award(A) | 15,625 | - | - | Direct |
| May 15, 2025 | OPRX OptimizeRx Corp | Award(A) | 46,948 | - | - | Direct |
| Mar 1, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 572 | $5.18 | $2,963 | Direct |
| Mar 1, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 1,928 | - | - | Direct |
| Feb 15, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 2,298 | $6.64 | $15,259 | Direct |
| Dec 23, 2024 | OPRX OptimizeRx Corp | Award(A) | 41,408 | - | $0 | Direct |
| Dec 19, 2024 | OPRX OptimizeRx Corp | Exercise(M) | 6,546 | - | $0 | Direct |
| Dec 19, 2024 | OPRX OptimizeRx Corp | Tax Payment(F) | 2,576 | $4.75 | $12,236 | Direct |
| Oct 3, 2024 | OPRX OptimizeRx Corp | Tax Payment(F) | 2,617 | $7.83 | $20,491 | Direct |
| Oct 3, 2024 | OPRX OptimizeRx Corp | Exercise(M) | 6,649 | - | $0 | Direct |
1-18 of 18 transactions
About Silvestro Stephen L
Silvestro Stephen L (SEC CIK 0001773461) files insider reports with the SEC as Chief Executive Officer of OptimizeRx Corp (OPRX).
Signal8 holds 14 ownership filings by Silvestro Stephen L, all Form 4s, filed between Oct 7, 2024 and Aug 24, 2026. Those filings report 18 transactions, from Oct 3, 2024 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Silvestro Stephen L's filings is in WALTHAM, MA.
Recent filings by Silvestro Stephen L
- Aug 21, 2026: Tax withholding of OPRX shares (Form 4, code F).
- Aug 20, 2026: Grant or award of OPRX shares (Form 4, code A).
- May 15, 2026: Tax withholding of OPRX shares (Form 4, code F).
- Dec 23, 2025: Tax withholding of OPRX shares (Form 4, code F).
- Dec 19, 2025: Tax withholding of OPRX shares (Form 4, code F).
Other insiders filing for OptimizeRx Corp (OPRX)
- D'Silva Andrew J., Chief Business Officer
- Merrell Brendan W., CHIEF OPERATING OFFICER
- Odence-Ford Marion, Chief Legal & Admin Officer
- Stelmakh Edward, Chief Finance & Strat Officer
- KLEMA CATHY, Director
- Lang James Paul, Director